The carbapenems and penem antibiotics—a brief review
- 31 October 1990
- journal article
- research article
- Published by Elsevier in Antimicrobic Newsletter
- Vol. 7 (10) , 73-78
- https://doi.org/10.1016/0738-1751(90)90045-e
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics of FCE 22891, a new oral penemAntimicrobial Agents and Chemotherapy, 1990
- Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101Journal of Antimicrobial Chemotherapy, 1990
- The postantibiotic effect of meropenem and imipenem on selected bacteriaJournal of Antimicrobial Chemotherapy, 1989
- The carbapenems: new broad spectrum -lactam antibioticsJournal of Antimicrobial Chemotherapy, 1989
- Pharmacokinetics of FCE 22101 in man following different modes of administrationJournal of Antimicrobial Chemotherapy, 1989
- In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility testsJournal of Antimicrobial Chemotherapy, 1989
- In-vitro studies of meropenemJournal of Antimicrobial Chemotherapy, 1989
- Imipenem/CilastatinDrugs, 1987
- Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatinThe American Journal of Medicine, 1985